Springhorn Jeremy P.

CIK 00017178522 companiesAMSTERDAM, P7

SEC Profile

Transactions

Companies

Filings

CIK

0001717852

Recent Transactions

37 trades

Sale
uniQure N.V.$QURE
Ordinary Shares
2025-06-20$14.45/sh−2,112→ 37,694 total
Award
uniQure N.V.$QURE
Stock Option (Right to Buy)
2025-06-11+15,630→ 15,630 total
Award
uniQure N.V.$QURE
Ordinary Shares
2025-06-11+7,970→ 39,806 total
Award
uniQure N.V.$QURE
Stock Option (Right to Buy)
2024-06-19+15,840→ 15,840 total
Award
uniQure N.V.$QURE
Ordinary Shares
2024-06-19+8,080→ 31,836 total
Sale
uniQure N.V.$QURE
Ordinary Shares
2024-06-13$5.12/sh−2,231→ 23,756 total
Sale
uniQure N.V.$QURE
Ordinary Shares
2023-06-16$18.88/sh−2,286→ 25,987 total
Award
uniQure N.V.$QURE
Ordinary Shares
2023-06-13+8,700→ 28,273 total
Award
uniQure N.V.$QURE
Stock Option (Right to Buy)
2023-06-13+17,060→ 17,060 total
Sale
uniQure N.V.$QURE
Ordinary Shares
2023-02-27$20.41/sh−384→ 19,573 total
Award
uniQure N.V.$QURE
Stock Option (Right to Buy)
2022-06-15+17,810→ 17,810 total
Award
uniQure N.V.$QURE
Ordinary Shares
2022-06-15+9,080→ 19,957 total
Sale
uniQure N.V.$QURE
Ordinary Shares
2022-02-28$16.70/sh−602→ 10,877 total
Award
uniQure N.V.$QURE
Ordinary Shares
2022-02-24+1,534→ 11,479 total
Award
uniQure N.V.$QURE
Stock Option (Right to Buy)
2022-02-24+2,645→ 2,645 total
Sale
uniQure N.V.$QURE
Ordinary Shares
2021-03-02$37.50/sh−505→ 9,945 total
Award
uniQure N.V.$QURE
Stock Option (Right to Buy)
2021-02-25+4,107→ 4,107 total
Award
uniQure N.V.$QURE
Ordinary Shares
2021-02-25+2,382→ 10,450 total
Award
Syros Pharmaceuticals, Inc.
Stock Option (right to buy)
2021-02-17+94,000→ 94,000 total
Award
uniQure N.V.$QURE
Ordinary Shares
2020-02-27+2,063→ 8,068 total
Award
uniQure N.V.$QURE
Stock Option (Right to Buy)
2020-02-27+3,620→ 3,620 total
Award
Syros Pharmaceuticals, Inc.
Stock Option (right to buy)
2020-02-13+94,000→ 94,000 total
Sale
uniQure N.V.$QURE
Ordinary Shares
2020-01-28$60.94/sh−4→ 6,808 total
Sale
uniQure N.V.$QURE
Ordinary Shares
2020-01-28$62.20/sh−803→ 6,005 total
Purchase
Syros Pharmaceuticals, Inc.
Common Stock
2019-11-12$4.97/sh+10,121→ 35,000 total
Purchase
Syros Pharmaceuticals, Inc.
Common Stock
2019-11-11$4.99/sh+9,879→ 24,879 total
Award
Syros Pharmaceuticals, Inc.
Common Stock
2019-02-12+87,000→ 102,000 total
Award
Syros Pharmaceuticals, Inc.
Stock Option (right to buy)
2019-02-12+75,000→ 75,000 total
Sale
uniQure N.V.$QURE
Ordinary Shares
2019-01-28$31.32/sh−1,210→ 6,812 total
Award
uniQure N.V.$QURE
Stock Option (Right to Buy)
2019-01-25+5,295→ 5,295 total
Award
uniQure N.V.$QURE
Ordinary Shares
2019-01-25+3,230→ 8,022 total
Award
uniQure N.V.$QURE
Ordinary Shares
2018-01-26+4,792→ 4,792 total
Award
uniQure N.V.$QURE
Stock Option (Right to Buy)
2018-01-26+6,390→ 6,390 total
Purchase
Syros Pharmaceuticals, Inc.
Common Stock
2017-12-15$9.08/sh+15,000→ 15,000 total
Award
Syros Pharmaceuticals, Inc.
Stock Option (right to buy)
2017-11-13+150,000→ 150,000 total
Award
Syros Pharmaceuticals, Inc.
Stock Option (right to buy)
2017-11-13+50,000→ 50,000 total
Award
uniQure N.V.$QURE
Stock Option (Right to Buy)
2017-09-20+10,000→ 10,000 total

Companies

Recent Filings

Address

C/O UNIQURE N.V. PAASHEUVELWEG 25A

AMSTERDAM, P7, 11058BP

View on SEC.gov